![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » VASOVIST RECOMMENDED FOR APPROVAL IN AUSTRALIA
VASOVIST RECOMMENDED FOR APPROVAL IN AUSTRALIA
August 16, 2006
The Australian Drug Evaluation Committee (ADEC) has recommended to the Therapeutic Goods Administration (TGA) that EPIX Pharmaceuticals' novel blood pool imaging agent Vasovist should be approved in Australia. However, the approval is subject to finalization of labeling. BioSpectrum (http://www.biospectrumasia.com/content/150806AUS1351.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct